Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Histologic transformation of EGFR mutant lung adenocarcinoma without exposure to EGFR inhibition

Published:2017-03 Issue: Volume:105 Page:14-16
ISSN:0169-5002
Container-title:Lung Cancer
language:en
Short-container-title:Lung Cancer

Author:

Le Tri,Sailors Joseph,Oliver Dwight H.,Mayer Melissa,Hoskin Sharon,Gerber David E.

Funder

National Cancer Institute Midcareer Investigator Award

Publisher

Elsevier BV

Subject

Cancer Research,Pulmonary and Respiratory Medicine,Oncology

Reference4 articles.

1. Histologic transformation from adenocarcinoma to squamous cell carcinoma as a mechanism of resistance to EGFR inhibition;Levin;J. Thorac. Oncol.,2015

2. Genotypic and histological evolution of lung cancers acquiring resistance to EGFR inhibitors;Sequist;Sci. Transl. Med.,2011

3. EGFR-driven behavior and intrapatient T790M mutation heterogeneity of non-small-cell carcinoma with squamous histology;Graziano;J. Clin. Oncol.,2015

4. Transformation to SCLC after treatment with the ALK inhibitor alectinib;Fujita;J. Thorac. Oncol.,2016

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Radiomics and deep learning models to differentiate lung adenosquamous carcinoma: A multicenter trial;iScience;2023-09

2. Rhabdomyosarcomatous Transformation as a Mechanism of Resistance to Osimertinib and Savolitinib in EGFR-Mutant Lung Adenocarcinoma With METamp After Osimertinib First-Line Treatment;JCO Precision Oncology;2022-10

3. Evolution and genotypic characteristics of small cell lung cancer transformation in non-small cell lung carcinomas;Journal of the National Cancer Center;2021-12

4. Gastric metastasis and transformation of primary lung adenocarcinoma to small cell cancer after acquired resistance to epidermal growth factor receptor tyrosine kinase inhibitors;Medicine;2021-10-01

5. Case Report: EGFR-Positive Early-Stage Lung Adenocarcinoma Transforming to Squamous Cell Carcinoma After TKI Treatment;Frontiers in Oncology;2021-06-08

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3